Artelo Biosciences's total assets for Q1 2024 were $10.35M, a decrease of -20.62% from the previous quarter. ARTL total liabilities were $817.00K for the fiscal quarter, a -36.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.